[Effect of antitumor preparations on the hemostatic system of oncological patients].
Effect of different antitumor drugs on the hemostasis system in oncological patients is shown to have many features in common. The differences mainly consist in the degree and duration of disorders, a shift of the balance toward hyper- or hypocoagulation, which was due to drugs toxicity with relation to the chains of the hemostasis system, individual susceptibility, the state of essential thrombocytopoiesis, etc.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001780:Blood Coagulation Tests; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008558:Melphalan / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*; D010976:Platelet Count; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D008558:Melphalan
Vliianie protivoopukholevykh preparatov na sistemu gemostaza onkologicheskikh bol'nykh.